Recommendations of the Spanish Society of Neonatology for the prevention of severe respiratory syncytial virus infections with nirsevimab, for the 2024-2025 season
- PMID: 39455352
- DOI: 10.1016/j.anpede.2024.09.010
Recommendations of the Spanish Society of Neonatology for the prevention of severe respiratory syncytial virus infections with nirsevimab, for the 2024-2025 season
Conflict of interest statement
Declaration of competing interest MSL has received fees for consulting and scientific meetings from Sanofi and AstraZeneca. All other authors have no conflicts of interest to declare.
Publication types
LinkOut - more resources
Full Text Sources
